Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2019
View Archived Issues
Discovery of novel HCV inhibitor L-0909
Read More
GlaxoSmithKline presents the discovery of GSK-778
Read More
Epigenetic inactivation of CELF2 associated with shorter overall survival in breast cancer
Read More
Phase II results support further study of AAV2-REP1 gene therapy in patients with choroideremia
Read More
Novel type of galactosemia caused by GALM gene mutations revealed
Read More
Study partially rehabilitates telomerase in cancer
Read More
Rock-paper-synthetic biology
Read More
Genentech describes lead small-molecule IRAK-4 inhibitors
Read More
Asthma symptoms have distinct origins, common target
Read More
PRC2 inhibitors patented by Shanghai Institute of Materia Medica, Suzhou Suplead Life Sciences
Read More
Bristol-Myers Squibb discovers STING agonists
Read More
FDA approves Ofev for interstitial lung disease associated with scleroderma
Read More
Phase I results of inhaled 5-azacytidine for the treatment of advanced non-small cell lung cancer
Read More
Enanta Pharmaceuticals discloses new farnesoid X receptor agonists
Read More
New PD-1/PD-L1 interaction inhibitors described by Gilead Sciences
Read More
AstraZeneca presents arginase-1 and arginase-2 inhibitors
Read More
Boehringer Ingelheim, Hydra Biosciences patent TRPC6 antagonists
Read More
Vicore completes phase I study of angiotensin II type 2 receptor agonist C-21
Read More
AstraZeneca reports phase III data on Imfinzi in previously untreated extensive-stage SCLC
Read More
Bristol-Myers Squibb designs RORgammaT inverse agonists showing biologic-like efficacy
Read More
Theravance reports first-in-human data on TD-8236 for inflammatory lung disease
Read More
Acadia's phase III study of pimavanserin in dementia-related psychosis meets primary endpoint
Read More
Passage Bio licenses gene therapy program for CMT2A from Penn
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe